Search Results - "KORST, A. E. C"

In vitro interaction between ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effects by SIMOENS, C, KORST, A. E. C, DE POOTER, C. M. J, LAMBRECHTS, H. A. J, PATTYN, G. G. O, FAIRCLOTH, G. T, LARDON, F, VERMORKEN, J. B

“…Ecteinascidin 743 (ET-743) is a new marine-derived agent with promising activity against a number of solid tumours. In four human tumour cell lines, the…”
Get full text

The radiosensitising effect of gemcitabine and the influence of the rescue agent amifostine in vitro by Pauwels, B, Korst, A.E.C, de Pooter, C.M.J, Lambrechts, H.A.J, Pattyn, G.G.O, Lardon, F, Vermorken, J.B

“…In this study, the radiosensitising effect of different concentrations of gemcitabine and the combination of gemcitabine/radiotherapy with the rescue agent…”
Get full text

Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient by KORST, A. E. C, GALL, H. E, VERMORKEN, J. B, VAN DER VIJGH, W. J. F

“…The pharmacokinetics of amifostine, a protector against chemotherapy and radiation-induced toxicities, was investigated in the plasma and ascites of a cancer…”
Get full text

Pharmacokinetics of amifostine and its metabolites in patients by Korst, A.E.C., Eeltink, C.M., Vermorken, J.B., van der Vijgh, W.J.F.

“…The pharmacokinetics of the cytoprotective agent amifostine (EthyolR; WR 2721) and its main metabolites (WR 1065 and the disulphides) were studied in patients…”
Get full text

Influence of amifostine on the pharmacokinetics of cisplatin in cancer patients by Korst, A E, van der Sterre, M L, Gall, H E, Fichtinger-Schepman, A M, Vermorken, J B, van der Vijgh, W J

“…The pharmacokinetics of cisplatin was investigated in 13 patients receiving 18 courses of cisplatin alone or in combination with amifostine to investigate the…”
Get full text

Amifostine (Ethyol®) : Pharmacokinetic and pharmacodynamic effects in vivo: Amifostine (ETHYOL®): current and future applications in cytoprotection by VAN DER VIJGH, W. J. F, KORST, A. E. C

Get full text

Pharmacokinetics of cisplatin with and without amifostine in tumour-bearing nude mice by Korst, A.E.C., Boven, E., van der Sterre, M.L.T., Fichtinger-Schepman, A.M.J., van der Vijgh, W.J.F.

“…Amifostine (Ethyol, WR-2721) is in use in the clinic as a protector against platinum-induced toxicities. We have previously reported that amifostine induced a…”
Get full text

Pharmacokinetics of carboplatin with and without amifostine in patients with solid tumors by KORST, A. E. C, VAN DER STERRE, M. L. T, EELTINK, C. M, FICHTINGER-SCHEPMAN, A. M. J, VERMORKEN, J. B, VAN DER VIJGH, W. J. F

“…We showed previously that amifostine (WR 2721; Ethyol), a protector against carboplatin-induced toxicities, changed the pharmacokinetics of carboplatin in…”
Get full text

High-performance liquid chromatographic assay using electrochemical detection for the combined measurement of amifostine, WR 1065 and the disulfides in plasma by Korst, A.E.C, Vermorken, J.B, van der Vijgh, W.J.F

“…A high-performance liquid chromatographic (HPLC) method was developed for the combined analysis of the chemoprotective agent, amifostine, its active…”
Get full text